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Abstract
Introduction: Sclerosing mesenteritis is a rare disease resembling a mesenteric tumour. We
present here a case of sclerosing mesenteritis that affected both the large and the small intestine
of the patient. Therapeutic and diagnostic issues are discussed.
Case presentation: A 62-year-old man with a history of non-Hodgkin lymphoma presented with
fatigue, a palpable tender abdominal mass and clinical signs of progressing intestinal obstruction.
The preoperative evaluation failed to prove recurrence of the lymphoma or any other definite
diagnosis. A laparotomy was performed through a midline incision. The mesentery resembled a
tumour-like thickened and fibrotic mass. Abundant, rigid intestinal loop adhesions were observed.
Diffuse fibrotic infiltration of the ileum and of the sigmoid colon, which obviously affected the
intestinal vascular supply, were identified. A right colectomy and partial sigmoidectomy were
performed. Pathological evaluation revealed extensive myofibroblastic reaction of the mesentery
with accompanying loci of fat necrosis and areas of inflammation. A diffuse fibrotic infiltration that
focally showed a ground-glass appearance was observed. The post-operative course was
complicated by respiratory insufficiency and infections and the patient died 2 months after the
operation.
Conclusion: Sclerosing mesenteritis that affects both the small and the large intestine is extremely
rare. The disease is characterized by myofibroblastic reaction, fat necrosis and diffuse fibrosis of
the mesentery. Pathological confirmation may be required for definite diagnosis. If the disease is
characterized by severe and diffuse fibrosis, then the application of surgical therapy may be
problematic.
Introduction
Sclerosing mesenteritis (SM) is a rare inflammatory
mesenteric disease characterized by chronic fat degenera-
tion and fibrosis; a disease that has become of clinical
interest during recent years [1,2]. Some authors described
this idiopathic disorder as mesenteric panniculitis (MP),
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mesenteric lipodystrophy and/or retractile mesenteritis
[3-6]. However, these terms may represent histological
variants of one single clinical entity [7]. The medical ther-
apy of SM is mostly empiric, and the application of radical
surgical therapy remains controversial [2,8]. We present a
rare case of SM that affected both the large and the small
intestine in a patient with non-Hodgkin lymphoma. Diag-
nostic and therapeutic issues with emphasis upon the sur-
gical treatment are further discussed.
Case Presentation
A 62-year-old Caucasian man of Greek origin was admit-
ted to our hospital with a 1-month history of progressive
fatigue, intermittent abdominal pain, weight loss, nausea
and vomiting. He was diagnosed with a moderately
malignant non-Hodgkin B-cell lymphoma 7 years previ-
ously. The patient had undergone chemotherapy for a 5-
year period followed by a complete remission of the dis-
ease. His regular follow-up showed no evidence of recur-
rence.
Physical examination revealed a palpable tender mass in
the left abdomen and scarce abdominal sounds. The rectal
examination was negative for blood and laboratory find-
ings were normal. The abdominal X-ray revealed dilated
intestinal loops and air-fluid levels (Figure 1A). Com-
puted tomography (CT) showed distended loops of the
small intestine. Colonoscopy revealed an erythematous
and oedematous appearance of the mucosa but no evi-
dence of inflammatory bowel disease. All pre-operative
investigations were inconclusive and the patient's clinical
state gradually deteriorated; therefore, a laparotomy was
performed through a midline incision. The mesentery was
thickened, fibrotic and constricted. There was a small
amount of serous effusion in the peritoneal cavity. No
enlarged lymph nodes were identified. Abundant, rigid
intestinal loop adhesions were observed. The symphysiol-
ysis that was performed proved technically difficult. Dif-
fuse fibrotic infiltration of the ileum and of the sigmoid
colon, which obviously affected the intestinal vascular
supply were identified. Hence, a right colectomy and a
partial sigmoidectomy were performed.
Pathological evaluation revealed an extensive myofibrob-
lastic reaction of the mesentery with accompanying loci of
fat necrosis and areas of inflammation (Figure 1B). Also,
ischaemic damage of the intestinal mucosa was docu-
mented, which could be attributed to the strangulation
and thrombosis of the vessels from the fibrotic process.
Finally, the histology of this fibrotic infiltration focally
exhibited a ground-glass appearance (Figure 1C). Immu-
nohistochemistry showed that the areas of increased
myofibroblastic activity were positive for vimentin,
desmin and b-cathepsin. Antibodies against CD-34, F-
VIII, HHF-35, CK5/6, CD-15, p53 and bcl-2 were nega-
tive. Ki67 was positive for a small population of nuclei.
CD-3 and L25 were negative for malignant lymphoma. In
conclusion, the pathological examination confirmed the
diagnosis of SM but failed to reveal any evidence of malig-
nancy [8,9].
Post-operatively, the patient exhibited respiratory insuffi-
ciency, thus he was admitted to the intensive care unit. His
clinical picture gradually deteriorated and he became sep-
tic. Despite prompt antibiotic administration, he died 2-
months after the operation.
Discussion
MP represents an idiopathic inflammatory mesenteric dis-
order. The disease is known in the literature with many
synonyms: mesenteric manifestation of Weber-Christian
disease, mesenteric lipodystrophy, mesenteric lipogranu-
loma and retractile mesenteritis [1-8]. An interesting char-
acteristic of MP is the pathological similarity between the
affected fatty tissue and that seen in Weber-Christian dis-
ease [10]. SM may be the final stage in the natural course
of MP; alternatively, MP and SM may represent histologi-
cal variants of one single clinical entity [7].
There are fewer than 300 cases of SM reported in the liter-
ature since the condition was first described in 1924 [11].
The majority of reported cases of SM involved the small
intestine; however, involvement of the large intestine may
occur but is extremely rare [1,12,13]. Other rare intra-
abdominal sites that were reported to be involved were
the mesoappendix, the peripancreatic area, the omentum,
the retroperitoneum and the pelvis [12].
A: Abdominal X-ray of the patient showing dilated intestinal  loops and air-fluid levels upon admission Figure 1
A: Abdominal X-ray of the patient showing dilated intestinal 
loops and air-fluid levels upon admission. B: Histological sec-
tion demonstrating zones of myofibroblastic reaction and 
inflammation, H&E × 63/. C: Histological section depicting 
loci of fat necrosis and fibrous tissue infiltration that focally 
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The pathogenesis of SM remains unclear. Autoimmune
disorders were suggested as a possible mechanism, while
other studies suggested that infection, trauma, ischaemia,
cold, different drugs, vasculitis, vitamin deficiency or
prior surgery could be involved in the pathogenesis
[1,7,14]. An association of SM with malignancy, namely
lymphoma, breast-, lung- and colon cancer, as well as
melanoma has been reported, which could further com-
plicate the diagnosis [1,12,14]. In our case, SM was diag-
nosed in a patient with a history of non-Hodgkin
lymphoma; however, no direct association was proved.
The diagnosis of SM is usually made by biopsy at laparot-
omy. The presence of a single, multiple or diffuse mass-
like inflammatory lesion in the mesentery, together with
a histological confirmation of fat necrosis and inflamma-
tory reaction or fibrotic infiltration in the mesenteric
lesions, strongly suggests the diagnosis of SM [1,3,6,9].
Magnetic resonance imaging may suggest the fibrous
nature of the lesion and delineates vascular involvement
[15]. Also, magnetic resonance imaging may show the
characteristic features of nonhomogeneous masses of >
fat- and soft-tissue density. The mass envelops the
mesenteric vessels. Over time, collateral vessels may
develop. The CT scan may depict the preservation of fat
around the mesenteric vessels, a phenomenon that is
referred to as the "fat ring" sign. However, CT cannot dis-
tinguish sclerosing mesenteritis from a primary or second-
ary mesenteric tumour [12,15].
SM is treated largely empirically. Corticosteroids, colchi-
cine, azathioprine, thalidomide, cyclophosphamide and
anti-inflammatory agents were suggested as possible ther-
apeutic agents; however, no definite results were docu-
mented [1,3,4]. Radical surgery still remains a
controversial therapeutic option [1,3,6,8,13]. In a previ-
ous report, the authors were in favour of surgical therapy
in the earlier stages of the disease [13]. However, with our
patient presented here pursuing surgical intervention
proved problematic. This was mainly due to the diffuse
fibrotic involvement of both the large and the small intes-
tine. This compromized both the vascular supply and the
peristaltic mobility of the intestine. Technical issues such
as the extensive symphysiolysis, the excision of a large part
of the non-peristaltic small intestine, and the difficult
mobilization-excision of the affected colon proved that
surgical intervention would offer only very limited advan-
tages in the late stages of the disorder.
Conclusion
SM that affects both the small and the large intestine is
extremely rare. The disease might resemble a mesenteric
tumour based on clinical, radiological and gross charac-
teristics. Histological confirmation is almost always
required. Medical therapy is empiric and surgical therapy
remains controversial. If the disease is characterized by
severe and diffuse fibrotic infiltration, then the surgical
results may be obscure.
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